Search Results - "Gavane, Somali C."

Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer by Fox, Josef J, Gavane, Somali C, Blanc-Autran, Estelle, Nehmeh, Sadek, Gönen, Mithat, Beattie, Brad, Vargas, Hebert A, Schöder, Heiko, Humm, John L, Fine, Samson W, Lewis, Jason S, Solomon, Stephen B, Osborne, Joseph R, Veach, Darren, Sawyers, Charles L, Weber, Wolfgang A, Scher, Howard I, Morris, Michael J, Larson, Steven M

“…Androgen receptor-signaling inhibitor (ARSi) drugs prolong life in metastatic castration-resistant prostate cancer (mCRPC), but such tumors eventually become…”
Get more information

Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot study by Schwartz, Melissa, Gavane, Somali C., Bou-Ayache, Jad, Kolev, Valentin, Zakashansky, Konstantin, Prasad-Hayes, Monica, Taouli, Bachir, Chuang, Linus, Kostakoglu, Lale

“…Purpose The purpose of the study was to assess the feasibility and diagnostic performance of FDG-PET/MR imaging compared to PET/CT for staging of patients with…”
Get full text

18F-FDG PET/CT in left ventricular assist device infections: In-depth characterization and clinical implications by Devesa, Ana, Rashed, Eman, Moss, Noah, Robson, Philip M., Pyzik, Renata, Roldan, Julie, Taimur, Sarah, Rana, Meenakshi M., Ashley, Kimberly, Young, Anna, Patel, Gopi, Mahmood, Kiran, Mitter, Sumeet S., Lala, Anuradha, Barghash, Maya, Fox, Arieh, Correa, Ashish, Pirlamarla, Preethi, Contreras, Johanna, Parikh, Aditya, Mancini, Donna, Jacobi, Adam, Ghesani, Nasrin, Gavane, Somali C., Ghesani, Munir, Itagaki, Shinobu, Anyanwu, Anelechi, Fayad, Zahi A., Trivieri, Maria Giovanna

“…Previous retrospective studies suggest a good diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET)/computed tomography…”
Get full text

Predicting malignancy in patients with adrenal tumors using 18F‐FDG‐PET/CT SUVmax by Vos, Elvira L., Grewal, Ravinder K., Russo, Ashley E., Reidy‐Lagunes, Diane, Untch, Brian R., Gavane, Somali C., Boucai, Laura, Geer, Eliza, Gopalan, Anuradha, Chou, Joanne F., Capanu, Marinela, Strong, Vivian E.

“…Background and Objectives 18F‐fluorodeoxyglucose positron emission tomography/computed tomography (18F‐FDG‐PET/CT) parameters may help distinguish malignant…”
Get full text

Predicting malignancy in patients with adrenal tumors using 18 F-FDG-PET/CT SUVmax by Vos, Elvira L, Grewal, Ravinder K, Russo, Ashley E, Reidy-Lagunes, Diane, Untch, Brian R, Gavane, Somali C, Boucai, Laura, Geer, Eliza, Gopalan, Anuradha, Chou, Joanne F, Capanu, Marinela, Strong, Vivian E

“…F-fluorodeoxyglucose positron emission tomography/computed tomography ( F-FDG-PET/CT) parameters may help distinguish malignant from benign adrenal tumors, but…”
Get full text

18F-FDG PET/CT In The Characterization And Management Of Continuous Flow Left Ventricular Assist Device Infection by Rashed, Eman, Devesa, Ana, Moss, Noah, Robson, Philip, Pyzik, Renata, Roldan, Julie, Mancini, Donna, Ashley, Kimberly, Gavane, Somali C, Ghesani, Munir, Contreras, Johanna, Lala, Anuradha, Parikh, Aditya, Young, Anna, Ghesani, Nasrin, Jacobi, Adam, Fayad, Zahi, Mahmoud, Kiran, Trivieri, Maria

“…Implantable continuous flow left ventricular assist devices (LVADs) are now more prevalent in end-stage heart failure treatment both as a bridge-to-transplant…”
Get full text

Metabolic tumor volume to predict event free survival in patients with relapsed/refractory HL treated with brentuximab vedotin-based salvage therapy by Gavane, Somali C., Ito, Kimiteru, Moskowitz, Craig H., Moskowitz, Alison J., Schöder, Heiko

“…Abstract only…”
Get full text

18 F-FDG PET/CT in left ventricular assist device infections: In-depth characterization and clinical implications by Devesa, Ana, Rashed, Eman, Moss, Noah, Robson, Philip M, Pyzik, Renata, Roldan, Julie, Taimur, Sarah, Rana, Meenakshi M, Ashley, Kimberly, Young, Anna, Patel, Gopi, Mahmood, Kiran, Mitter, Sumeet S, Lala, Anuradha, Barghash, Maya, Fox, Arieh, Correa, Ashish, Pirlamarla, Preethi, Contreras, Johanna, Parikh, Aditya, Mancini, Donna, Jacobi, Adam, Ghesani, Nasrin, Gavane, Somali C, Ghesani, Munir, Itagaki, Shinobu, Anyanwu, Anelechi, Fayad, Zahi A, Trivieri, Maria Giovanna

“…Previous retrospective studies suggest a good diagnostic performance of F-fluorodeoxyglucose positron emission tomography ( F-FDG-PET)/computed tomography (CT)…”
Get full text

Pathologic correlation of 18F-16β-fluoro-5α-dihydrotestosterone (FDHT) and FDG PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) by Feldman, Jarett L., Fox, Josef J., Martinez, Danny F., Autio, Karen A., Durack, Jeremy C., Humm, John, Schöder, Heiko, Gavane, Somali C., Curtis, Kristen Rebecca, Balakirsky, Samantha Meredith, Cohen, Rachel Mathilda, Scher, Howard I., Larson, Steven M., Morris, Michael J.

“…Abstract only…”
Get full text

Evaluating 18F-16β-fluoro-5α-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA) by Feldman, Jarett Lawrence, Fox, Josef J., Autio, Karen A., Gavane, Somali C., Heller, Glenn, Schöder, Heiko, Humm, John, Martinez, Danny F., Slovin, Susan F., Scher, Howard I., Larson, Steven M., Morris, Michael J.

“…Abstract only 56 Background: There are no available imaging biomarkers that can prognosticate for clinical outcomes for patients treated with AA. FDG and FDHT…”
Get full text